| Variables | Chrnic HBV (N = 74) | Chrnic HCV (N = 74) |
| Age (years) Mean ± SD | 50.4 ± 9.1 | 52.2 ± 9.5 |
| Sex (N%) - Male - Female |
39 (52.7%) 35 (47.3%) |
41 (55.4%) 33 (44.6%) |
| Viral load - Mild
- Moderate
- High
|
25 (33.8%) (16 - 100,000) 25 (33.8%) (100,000 - 1,000,000) 24 (32.4%) (>1,000,000) |
25 (33.8%) (20,000 - 100,000 IU/ml) 25 (33.8%) (100,000 - 500,000 IU/ml) 24 (32.4%) (>500,000 IU/ml) |
| Responder patients (N%) | 63 (85.14%) | 72 (97.30%) |
| Pretreatment degree of liver stiffness (kpa) (Mean ± SD) | 7.19 ± 3.11 | 7.36 ± 3.26 |
| Osteopontin (Mean ± SD) | 82.31 ± 45.42 | 78.73 ± 48.02 |
| AST (U/L) (Mean ± SD) | 62.68 ± 18.93 | 48.27 ± 22.42 |
| ALT (U/L) (Mean ± SD) | 67.72 ± 21.81 | 51.62 ± 26.07 |
| Bilirubin (mg/dl) (Mean ± SD) | 1.18 ± 0.23 | 1.11 ± 0.29 |
| Albumin (g/dl) (Mean ± SD) | 3.99 ± 0.52 | 4.08 ± 0.64 |
| Platelets (×103/ul) (Mean ± SD) | 213.84 ± 73.81 | 214.51 ± 77.58 |
| INR (Mean ± SD) | 1.08 ± 0.15 | 1.07 ± 0.16 |